Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australian company in deal with Ethicon:

This article was originally published in Clinica

Executive Summary

Polartechnics of Australia is to link up with Johnson & Johnson subsidiary Ethicon to commercialise its cervical cancer and pre-cancer detection device, Polarprobe. The company's share price rose by over 20% on the news that Ethicon would be spending $18 million, subject to certain, unspecified milestones. Polartechnics will retain rights to market the product in Australasia, Taiwan, South Korea, the Philippines, Singapore, Malaysia and Indochina.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT085150

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel